Depression, anxiety, addictions, neurological disorders, palliative care, psychosomatic illnesses, and if the solution to many ailments lay in the psychedelics ? This proposal may seem astonishing and yet ! Since the beginning of the years 90, we are witnessing a boom in scientific research on molecules long decried for their dangerousness and therefore banned. LSD, psilocybine, MDMA, mescaline, we now discover that they are not drugs but rather super drugs.
LSD versus Prozac? Through this documented investigation, I reveal to you the multiple applications of psychedelic therapies that, like quantum medicine, could revolutionize our conception of health and consciousness.
Dossier by Pryska Ducoeurjoly published in Neo Health number 88
Il and 10 years, Doctor Olivier Chambon published a pioneering work[1]: Psychedelic medicine, the therapeutic power of hallucinogens. This first book in French written by a doctor revealed to the general public the interest of psychoactive chemical substances called psychedelics, such as psilocybin, la mescaline, LSD or DMT. “The book was greeted with deafening silence by the media. This is a scary subject because there is a lot of misinformation about these substances, wrongly qualified as drugs. They are actually “super drugs”, whose effectiveness is superior to many conventional treatments”.
that they are of natural or synthetic origin, these substances mainly require to be employed in a secure medical environment, like the one proposed by experimental protocols of current research. "These drugs potential could then allow real progress in many areas, starting with psychiatry, whose practices have not changed since 20 year old, explains Olivier Chambon.
The term psychedelic means "allowing the manifestation of the spirit or the soul". It was proposed in 1957 by Dr. Humprey Osmond, a british psychiatrist. Like him, many psychiatrists for years 50 experimented on themselves (and on their patients) molecules like LSD and psilocybin. They very quickly understood the interest of these substances in the resolution of mood disorders, but they were also subjugated by the consciousness expansion phenomena.
The first wave: a tsunami!
As the reminds doctor Olivier Chambon, psychedelic medicine is first and foremost “the story of a first birth that went wrong : In Occident, between 1947 and 1976, there has been a phenomenal explosion of interest in research (both inside and outside the laboratories). During this period, plus de 700 articles were published in peer-reviewed journals reading, attesting to the safety and efficacy of psychedelics, and rewarding clinical practice and research methodology. Countless publications described the evolution of some 40,000 patients who took participate in psychedelic-assisted therapy (TAP) or testing clinics, and several dozen books have appeared on the subject. The psychedelics were then considered the tools for exploring the most promising human mind that psychology has ever seen. »
Corn the scientific euphoria ended with the ban on the consumption of psychedelics in 1966: LSD had come out of the laboratories under the impetus of activist psychologist Timothy Leary, and led to a uncontrolled consumption within the hippie counterculture. Unsustainable for the dominant capitalist system… From 1968, research was also prohibited, and many researchers were left stunned by the abrupt end of their exciting work. This will not prevent the CIA from using LSD in the framework for illegal experimentation on human subjects in Canada and the United States as part of the MK-Ultra mind manipulation project… It will take wait 1992, for the US FDA to authorize the resumption of research, thanks to the tenacity of Doctor Rick Strassman for the study of DMT (see our lexicon). other time, other customs, the US agency supports now several clinical trials.
the US agency supports now several clinical trials
the US agency supports now several clinical trials, the US agency supports now several clinical trials (the US agency supports now several clinical trials, the US agency supports now several clinical trials, the US agency supports now several clinical trials, the US agency supports now several clinical trials), the US agency supports now several clinical trials. the US agency supports now several clinical trials, the US agency supports now several clinical trials, the US agency supports now several clinical trials 2 and 3, the US agency supports now several clinical trials (the US agency supports now several clinical trials). the US agency supports now several clinical trials, the US agency supports now several clinical trials: depression, the US agency supports now several clinical trials, the US agency supports now several clinical trials, the US agency supports now several clinical trials…
Even if the the academic world still looks at this revival with a funny eye, three American associations and three European associations play the patrons: la Maps (Multidisciplinary association for psychedelic studies, maps.org), le Heffter research center (heffter.org), the beckley foundation (England), the Russian Psychedelic Society and the Swiss Association for psycholytic therapy (seven). In France, research remains prohibited, same if there is a French psychedelic society, who mediates cultural and scientific on this theme.
" The reintroduction could be done first within the framework of research therapy in a hospital setting, offers Olivier Chambon. The goal would be to reassure public opinion by demonstrating the interest of psychedelics for targeted populations under conditions of use well controlled and monitored. This is the first step to decondition the minds over decades of misunderstanding, even hysteria and paranoia ».
LSD versus Prozac : what is a drug?
did you know that psychedelics are not addictive? It is indisputably proven! Better, scientific studies are rediscovering their great drug addiction potential. They do not entail flight from reality or isolation. Au contraire, psychedelics bring a more acute perception external and internal realities, increase empathy towards the surroundings, develop ecological and spiritual awareness.
In English, the term drug designates any type of medicinal substance. Corn scientifically, real drugs are classified into two categories : the stimulating, like caffeine, cocaine, nicotine, amphetamines; and sedatives, like opiates (including the heroine), benzodiazepines (Valium) or alcohol. “Psychedelics belong to a third category of substances, the one that modifies the “quality" consciousness rather than accentuating or reducing processes mental”, explains Doctor Chambon.
Other size difference with real drugs and more widely with other conventional drugs, their safety. It is evaluated through the “index therapeutic", classical measure of acute toxicity which is defined by the relationship between the dose that kills 50 % subjects and the dose that is effective in 50 % cases. “The higher the index, the better the security profile medicine. Gold for psychedelics like LSD or psilocybin, this index is 600. These substances are particularly safe ! With little lethal risks when compared to others like aspirin (199) or the nicotine (21) », says Olivier Chambon. And quote an anecdote: Aspirin is a drug, peyolt is sacred”, response from a shaman huichol indian (Mexico) to a journalist calling this mescaline cactus like a drug.
bad media trip
The psilocybin or LSD have been tried by millions and rare are the number of deaths compared to the number of doses swallowed over several decades. But the media tends to jump on the rare cases of incidents under psychedelics, sometimes falsely attributed to their job. "This has not of scientific value. It's a bit like focusing only on the traffic accidents to say the car should be removed, negligent the vast majority of daily journeys that, fortunately, negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that.
Result, negligent the vast majority of daily journeys that 2018, negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that. Yet, negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that,[2] negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that.
negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that: negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that, negligent the vast majority of daily journeys that, a suitable dosage, and especially the exclusion of certain drug interactions or certain psychological profiles incompatible with these therapies. “It is not a question of reproducing the abuses of the 60s–70s, but to enroll in the Vidal a new class of medications ", argues Doctor Chambon.
Hallucinations or revelations ?
Almost all psychedelics are alkaloids, divided into two families chemicals : phenethylamines (mescaline, MDMA or ecstasy) and tryptamines (DMT, psilocybine, LSD, ibogaine and others). They mainly act on the cerebral circuit of serotonin (precisely the 5–HT2A receptor). The phenethylamines further act through dopamine and norepinephrine, neurotransmitters primarily responsible for stimulatory effects. Those families of molecules cause hallucinations. But these hallucinations would they not rather be symbolic visions of another reality? Many researchers are now convinced of this.. Besides, reality ordinary itself could only be a hallucination produced by our brain because, for quantum physics, “true” reality is only composed only emptiness and moving particles…
Unlike psychotic hallucinations, produced by a mental disorder, the visions under psychedelics can be particularly coherent and creative. They provoke a feeling of revelation, a “eureka” !” of consciousness giving birth to something bigger than yourself. Didn't two Nobel Prize winners admit having been inspired by LSD? The double helix structure of DNA (Francis Crick), and the polymerase chain reaction method (CRP), fluently used by laboratories (Karry Mullis), are the result of visions psychedelics… Isn’t it mind blowing?
Explanations of magnetic resonance
In two studies of 2012,[3] Robin Carhart-Harris and his colleagues at Imperial College London are highlighting evidence, sub psychedelic, a decrease in the activity of certain areas important to the brain, especially in the medial prefrontal cortex and the cortex posterior cingulate, two very important centers in consciousness, the sense of self and decision making. They are like "asleep". In parallel, other communication areas get busy, allowing the subject to have access to more personal memories.
Pour Robin Carhart-Harris, we can talk about putting the cerebral “default mode” on standby under the influence of these substances, which lead at the same time to a sort of reset, that is to say a cleansing of emotional pollution or limitations existential. This resets the counters to zero., mend the wounds by integrating into a broader vision and allows you to reorient your life towards more of well-being, a better lifestyle and fewer relational conflicts.
Very broad therapeutic indications, according to the research
Tobacco, addictions and drug addiction. The psychedelics can cure drug addiction, of the lightest (café, tobacco, certain medications), to the hardest (heroin, cocaine, amphetamines). They can also reduce or eliminate withdrawal symptoms. For tobacco for example, a pilot study from Hopkins University[4] (2017) shows that with three doses of psilocybin 80 % of patients no longer smoke cigarettes after six months, and 67 % after twelve months, a level widely superior to conventional drugs (35%). The “mushrooms” are more effective than Champix… This study was only conducted on 15 patient but it is already very promising since it was about people smoking a packet per day since 30 years on average.
The Depression. We know that psychedelics have an action on serotonin receptors. So that's all naturally they have been tested as an alternative to antidepressants classics such as selective serotonin reuptake inhibitors. Robin Carhart-Harris showed that psilocybin works well superior to conventional treatment for severe incurable depression. In a study published in 2018 bearing on 20 patients, it shows how two doses of psilocybin given as part of a protocol of several preparation and integration sessions not only provide relief immediate but also long-term beneficial effects (6 month).[5]
In 2018, the FDA recently granted “Breakthrough Therapy” designation (breakthough therapy) to the use of psilocybin in depression, which will allow accelerate time to market. This concerns a phase 2b clinical trial, whose goal is now to determine the optimal dose.
350 million people worldwide suffer from depression, it is the equivalent of people of the united states. As Robin Carhart-Harris recalls,[6] this pathology is not something that can be swept under the rug : she cost 200 billion dollars each year in the United States and represents the leading cause of death in men under the age of 45 years in Britain. 50 stamps for 1000 inhabitants, is the annual consumption of antidepressants in France…” 15 % people with depression commit suicide, reminds the researcher. And 50 % of the population responds to treatment conventional, there are still 20% of people for whom this does not not working".
Mood disorders in general. More usually, recent randomized, placebo-controlled studies have revealed that psilocybin (chez 25 adults, Carhart-Harris 2016 ) and LSD (chez 20 adults, Kraehenmann 2015) are associated with increased positive mood and psychological well-being. They confirm other work demonstrating the antidepressant effects or anxiolytics from psychedelics like LSD, psilocybin and Ayahuasca.[7]
severe premenstrual syndrome. the female cycle premenstrual syndrome is a life poisoning disorder many women. In its severe form, she is cared for by antidepressant, like Prozac, or by synthetic hormones. or by synthetic hormones, or by synthetic hormones 2016, or by synthetic hormones,[8] or by synthetic hormones, or by synthetic hormones, or by synthetic hormones
or by synthetic hormones. or by synthetic hormones : close to 10 000 or by synthetic hormones. or by synthetic hormones. or by synthetic hormones (or by synthetic hormones, or by synthetic hormones, or by synthetic hormones) can be relieved by psychedelics. A large study of 2015 involving 190,000 people showed that psychedelics decrease the risk of suicide, while the drugs on the contrary make it worse.[9]
Social and domestic violence. According to one American study of 2014[10] wearing out of 25,000 prisoners, people who have used psychedelics are less likely to relapse into alcoholism or other drugs. They also adopt a more “pro-social” attitude, reducing the risk of criminal recidivism ("anti-social"). Another one study published in 2016 and relating to 300 inmates, also shows that the psychedelics cut domestic violence in half, while braking “the externalization of mental pathology”, i.e. the transition to the act.[11]
In 2018, a study[12] conducted in the general population confirms: “The consumption of certain drugs like alcohol, methamphetamine or cocaine is often associated with increased aggression and domestic violence. The use of psychedelics seem to have the opposite effect”, says Michelle Thiessen, lead author of the study.
For the Doctor Olivier Chambon, psychedelics might even be helpful in couples therapy : “MDMA releases oxytocin present in this organ, via stimulation of serotonergic receptors. But oxytocin is a hormone involved in attachment, love, ecstasy. There is a loop regulation between the heart and the emotional brain, which brings relief and enhanced cognitive abilities. As the therapists said 70s–80s, cited by Saunders (1996) : MDMA is unique in that she overcomes inhibitions and very quickly leads the subject of hatred to love and understanding of others”.
Post-traumatic stress (TSPT). It is especially MDMA which is being studied for this indication, within the framework of a psychedelic-assisted psychotherapy» (PAP). Randomized trials tested in the United States and Switzerland demonstrated improvements significant long-term effects in patients with drug-resistant PTSD treatments, like american veterans, through assisted psychotherapy (Mithoefer, 2013, 2018; Oehen, 2013).
others research continues in an international clinical trial of phase 3, sponsored by MAPS, association supporting research on psychedelics mentioned above. This association hopes to obtain a marketing authorization for MDMA as a drug for PAP from here 2021. To do this, the maps coordinates a financing plan of more than 25 millions of dollars!
Anxiety in oncology. Of them double-blind, randomized controlled trials of 80 affected patients Cancer Tested Psilocybin for Depression and Symptoms anxious (Griffiths et al., 2016; Ross et al., 2016). Roland Griffiths, professor at Johns Hopkins University, Explain : "a diagnosis of life-threatening cancer can be psychologically challenging, with some very common symptoms of anxiety and depression”. A single dose of psilocybin causes both an immediate and long-lasting positive effect (out of six month) chez 80 % some participants, less anxious about death ».
Palliative care. The psychedelics could thus represent a valuable aid in the care palliatives. They relieve physical and mental pain. An alternative credible to palliative sedation, which consists of a decrease in the consciousness through the administration of medication. Psychedelics can contrary to restore meaning to the experience lived in this final passage, with a mindful acceptance of death. They could also provide those around you with a more satisfactory solution than sedation palliative for their loved one.
The psychedelics teach another view of earthly reality, which allows to “relativize” physical death, source of anguish or anxiety in the majority of humans.
Autism anxiety. A another double-blind pilot study[13] show that MDMA improves the comfort of life of autistic people. driving on 12 patients, in partnership with the FDA and with financial support from MAPS, the study has revealed significant and lasting reductions in social anxiety after two MDMA-assisted psychotherapy sessions. The study also demonstrated safety in a controlled therapeutic environment. This molecule known to generate more empathy is ideal for the management social phobias in general.
Obsessive Compulsive Disorders, the eating disorders. A small study[14] phase I performed on 9 people demonstrated dramatic improvement in all subjects after four doses of psilocybin. At the house of 7 topics, the decrease in symptoms is of 50 % for more than 24 hours. Two subjects saw their improvement lasting for a week, a third went into remission complete at 6 month[15]. The psychedelics may also be helpful in eating disorders, anorexia and bulimia.
Facial pain. Occasionally called "suicidal headache" so much the pain makes you want to throw yourself window, the pain of the face is poorly treated (73 % failure). In a study published in 2006[16] by one harvard team, psychedelics block seizures, delay their arrival or even completely make them disappear. A search to deepen urgently for those people who suffer from this pathology.
Parkinson, Alzheimer… The psychedelics have a protective action, even antidegenerative on the brain. Ibogaine is thus evaluated in the treatment of the disease Alzheimer's. L’harmine (contained in ayahuasca) again subject of interest for the treatment of various forms of this disease.
" From researchers at the University of South Florida are studying the action of psilocybin as a facilitator of the birth of the development of new brain cells (neurogenèse) in an area of the human brain, the hippocampus, associated with learning and memory, explains Olivier Chambon. The study of the Hoasca Project, on long-term ayahuasca users in Brazil shows that there is no cognitive deficit in these people, corn that in addition most of them have better brain performance. Even among those over 80 years, this study describes remarkable mental acuity and great physical vigor.
We is now starting to see other explanations for Alzheimer's disease. According to psychologist Bernard Sensfelder, it would come from an anguish of the death and emotional turmoil, that lead to functional deviations (and not structural) in nerve impulses. This practitioner has set up a light hypnosis therapy, the eïnothérapie, already practiced in several nursing homes in France, with healings in people with early Alzheimer's. This work better explains why psychedelics might be particularly suitable for improving brain health.
Burnout and psychosomatic illnesses. The psychoactive substances have the ability to expand consciousness beyond the self to resolve emotional or existential conflicts responsible for various pathologies (evil of, migraines, etc.). Psychedelics, it's THE medicine psycho-somatic par excellence. It is moreover in this sense that it is used in shamanic medicines for many indications, both mental and physical.
malaise at work, chronic anxiety, depression… Saturated with materialism, numerous Westerners live in an existential impasse. Their enthusiasm for traditional shamanism is a reflection of this need for more natural therapies comprehensive integrating the spiritual aspect, from which medicine amputated us western.
The need for a framework therapeutic
" Has my meaning total liberalization is not desirable : these substances are too powerful and too serious not to require a minimum of precautions and respect in their use; The clinical literature agrees that psychedelics are generally safe and effective when taken used as agreed.
"Like any tool, they should be used by properly trained people. They would allow then to reduce the social security hole, because their rapid effectiveness, in a few takes, generate much less expense than daily intake spread over many months, even years, antidepressant treatment, tranquilizers, analgesics or other. Another potential source of savings comes from the proven ability of its psychedelics to treat very effectively difficult populations (drug addicts, alcoholics).
When will psychedelic drugs arrive? ?
" We can always dream, But I'm afraid that's utopian, comment Olivier Chambon. There is a good chance that it will remain the privilege of some insiders ». Psychedelic medicine like quantum physics profoundly upsets the materialistic spirit and its phobia of altered states of conscience. “Our society is too cognitive-centrist, considering the ordinary state of consciousness as the only position of credible observation and the only valid source of useful information and knowledge”, deplore Olivier Chambon.
Those molecules are subversive because they can allow the population to free from certain manipulations. Those molecules are subversive because they can allow the population to free from certain manipulations, Those molecules are subversive because they can allow the population to free from certain manipulations, Those molecules are subversive because they can allow the population to free from certain manipulations, Those molecules are subversive because they can allow the population to free from certain manipulations. Those molecules are subversive because they can allow the population to free from certain manipulations (2006), Those molecules are subversive because they can allow the population to free from certain manipulations, Those molecules are subversive because they can allow the population to free from certain manipulations. Those molecules are subversive because they can allow the population to free from certain manipulations.
Those molecules are subversive because they can allow the population to free from certain manipulations 50 years of prohibition of psychedelics for market molecules with side effects today widely decried. There is no doubt that the laboratories are already thinking about the best way not to miss the train of the psychedelic revolution, territory, unfortunately for them, weakly patentable. Billions of dollars are stakes.
In the meantime, the prohibition of the consumption of psychedelics mainly benefits a use illegal and non-conscious recreational, not conducive to releasing the benefits of these substances, but rather encouraging abuse, toxic cocktails, bad guys dangerous trip, psychotic episodes, the exact opposite of the use shamanic traditional : a sacred ritual for soul medicine. Beware of interactions with other psychotropics or drugs! The taking of some psychedelic can be dangerous with anti-depressants, the alcohol, the noise or the overheated atmospheres of techno parties.
The three favorite psychedelics de la science
The doctor Chambon nevertheless believes that ketamine could be the first molecule authorized for psychedelic-assisted therapies, because it is the alone already employed in medicine (as an anesthetic). The laboratory Janssen (Johnson group & Johnson) is very interested in it for a new treatment for depression.[17] Committed in thirty countries, his clinical trial conducted on esketamine (the cousin of ketamine) involves Sainte-Anne Hospital, en France, under the direction of Dr. de Maricourt. It is undoubtedly the only psychedelic with power be studied in France. La Food & Drug Administration (FDA), the gendarme american health, granted the privileged status of “innovative therapy” to the Janssen molecule to make it available more quickly.
the scientist Robin Carhart-Harris wants to be optimistic for psilocybin. She is getting closer to legalization as an alternative to antidepressants because it is a natural molecule, whose effects last less than the highly stigmatized LSD. On the MAPS side, MDMA is also believed to be in good pathway as post-traumatic stress medication.
A thing is safe, mentalities are changing and the second wave of research on psychedelics started. Works like "Healing when it's impossible ", d’Antoine Sénanque, shows that a more spiritual medicine is desired by many physicians, empathetic to the distress of their patients.
LEXICON PSYCHEDELIC
The number of psychoactive substances is very important. You can get an overview at the Wikipedia of “psychonauts”,[18] term which refers to current users, numerous, psychoactive substances. here is the main.
Psilocybine. Active ingredient of some hallucinogenic mushrooms, he was first isolated by Albert Hofmann in 1958 from sclerotia of psilocybe mexicana, consumes traditionally in Mexico. This molecule, present in proportions variables in many fungi, is classified by the UN as one of the “substances with abuse potential presenting a serious risk to public health and low therapeutic value”. The effects last Between 4 and 9 hours depending on dosage and mode of administration.
Iboga. Small African shrub from the equatorial forest, the roots contain twelve alkaloids, including ibogaine, psychostimulant and hallucinogenic. These roots are used finely cut into strips or grated to form a powder. Classified as narcotic, its culture and its consumption are prohibited in France and in many countries. The research considers ibogaine to be one of the best potential treatments for addictions (cocaine, heroin, morphine, opium, alcohol, nicotine).
Mescaline. This molecule is present in different cacti like peyote and san pedro. In "Doors perception", paru en 1954, Aldous Huxley recounts his experience with mescaline. Several decades of observation in populations natives have documented its effectiveness against alcoholism in particular and drugs in general, without toxic effects even in long-term use.
Ayahuasca. Classified in France as amazing in 2005, but allowed since 2006 US, this vine Amazonian is traditionally used in shamanism. The book of Jeremy Narby, "The Cosmic Serpent", made him famous, as well as Jan Kounen's film, "Other Worlds". Scientific data confirm its safety when taken in an adequate setting. The ancestral preparation (which includes another plant, the chacruna) contains psychoactive substances like DMT, harmine and harmaline. We now know that the human brain produces Also, via la glans pinéale, DMT and pinoline, close to harmine.
LSD. Fortuitously synthesized by the Swiss chemist Albert Hofmann in 1943, lysergic acid diethylamide is a derivative of ergot which belongs to the same family as psilocybin. From plants of the convolvulaceae family such as Ipomoea tricolor contain ergoline-derived alkaloids like ergine (LSA) in their seeds, used in a ritual setting on the South American continent by pre-Columbian populations. In 1971, LSD is classified by the UN as one of the substances with potential for abuse presenting a serious risk to health public and low therapeutic value. » In 2006 in the United States it was estimated that 23 million the number of Americans who have ever used LSD and 600 000 annual consumers.
MDMA also called MD or ecstasy, belongs to the amphetamine family, also close to the hallucinogen mescaline. It has empathogenic and stimulating effects. Classified as narcotic, his use as a recreational drug has become commonplace over the years 90, with the advent of the techno movement. In France, in 2010, we estimated the number experimenters (at least once in their life) around 1,1 million and current users at approximately 150 000.
Ketamine. Well-known molecule of anesthetists for years 60 and clubbers for its effects euphoric, we discovered its benefits on the mood a little by chance, to early years 2000. No long-term behavioral changes or personality disorder results from the use of ketamine according to the studies. “Dissociative anesthetic”, it disconnects the mind from body. At doses ten times lower than those typically used in surgery for general anesthesia, it allows a psychedelic experience deep lasting about an hour.
DMT. The human brain naturally produces a
a substance very similar to LSD called dimethyltryptamine (DMT). This
substance is present in many plants and in the brain of all
mammals. It is called a “universal psychedelic”.
[1] The arenas, 2009.
[2] “Drug harms in the UK: a multicriteria decision analysis.” Nutt et al. Lancet 2010.
[3] “Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin”. Carhart-Harris et al. Br J Psychiatry, 2012. “Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin”. Carhart-Harris et al. Proc Natl Acad Sci USA 2012
[4] “Long-term follow-up of psilocybin-facilitated smoking cessation”. Johnson MW, Garcia-Romeu A, Griffiths RR. Am J Drug Alcohol Abuse. 2017
[5] “Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.” Carhart-Harris et al. Psychopharmacology, 2018
[6] Psychedelics: Lifting the veil, Robin Carhart-Harris, TEDxWarwick
[7] “Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years”. Dos Santos et al.. Ther Adv Psychopharmacol 2016
[8] www.ayeletwaldman.com
[9] “Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population”. Hendricks et al. J Psychopharmacol 2015
[10] “Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision”. Hendricks et al. J Psychopharmacol, 2014
[11] “Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use”. Walsh et al. J Psychopharmacol, 2016
[12] “Psychedelic use and intimate partner violence: The role of emotion regulation”, Thiessen et al, J Psychopharmacol 2018
[13] “DMA-assisted therapy: A new treatment model for social anxiety in autistic adults”. Alicia et al. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2015
[14] Moreno FA et al. J Clin Psychiatry 2006
[15] “Psilocybin and OCD” (A. Bottero) in Neuropsychiatrie : Trends and Debates 2007
[16] “Response of cluster headache to psilocybin and LSD”, Sewell et al. Neurology 2006
[17] "The new weapons from the labs against depression. The echoes. 7 April 2017.
[18] psychonautwiki.org
Related Articles
Keywords: Ayahuasca, IBOGA, LSD, Medicine, psychedelic, psychotropic